CN110974882A - Medicinal powder and lotion for treating hemorrhoid and preparation method thereof - Google Patents
Medicinal powder and lotion for treating hemorrhoid and preparation method thereof Download PDFInfo
- Publication number
- CN110974882A CN110974882A CN201911389193.3A CN201911389193A CN110974882A CN 110974882 A CN110974882 A CN 110974882A CN 201911389193 A CN201911389193 A CN 201911389193A CN 110974882 A CN110974882 A CN 110974882A
- Authority
- CN
- China
- Prior art keywords
- parts
- hemorrhoid
- stirring
- solution
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to hemorrhoid medicinal powder, hemorrhoid lotion and a preparation method thereof, wherein the hemorrhoid medicinal powder comprises the following components in parts by weight: 5-10 parts of astragalus membranaceus, 15-25 parts of golden cypress, 15-25 parts of radix angelicae, 10-20 parts of dandelion, 10-20 parts of fructus cnidii and 15-25 parts of purslane. The hemorrhoid lotion comprises the hemorrhoid powder and also comprises the following components: purified water, water-soluble algefacient, A.ASP antibacterial agent; the mixture ratio of each component is as follows: the hemorrhoid treatment solution comprises, by weight, 60-90 parts of purified water, 10-20 parts of hemorrhoid powder, 1-3 parts of water-soluble freshener and 1-5 parts of A.ASP antibacterial agent. The hemorrhoid powder and hemorrhoid lotion do not contain components of Moschus, sanguis Draxonis, Borneolum Syntheticum, calculus bovis, Alumen, hormone or antibiotic which are forbidden to be used with caution for pregnant women, and can help pregnant and lying-in women hemorrhoid patients get rid of pain, swelling, hemorrhage, etc. caused by hemorrhoid.
Description
Technical Field
The invention relates to the technical field of hemorrhoid medicines, in particular to hemorrhoid medicine powder, hemorrhoid lotion and a preparation method.
Background
Hemorrhoid is a common anorectal disease, and is a soft venous mass formed by varicose veins under the mucosa of the end of the rectum and subcutaneous veins of the anal canal. According to data statistics, the incidence rate of the adult suffering from the hemorrhoid disease reaches 60-73%, the incidence rate is related to sedentariness, little activity, constipation, diarrhea, too long defecation time, drinking and preference for spicy diet, and the incidence rate of women is higher than that of men. In recent years, the incidence of disease has increased dramatically due to changes in dietary structure and dietary habits. Hemorrhoids cause uneasy sitting and lying and difficult pain of human body.
Hemorrhoids are a frequently encountered disease due to the changes of psychological state, physiological structure, hormone in vivo and the like of pregnant and lying-in women. According to statistics, the incidence rate of hemorrhoids of pregnant and lying-in women is up to 76%, wherein the severe proportion is 28.1%. In any situation, the diet of pregnant and lying-in women is random at present, and the incidence rate of hemorrhoids during pregnancy is greatly increased. If haemorrhoids exist in pregnancy, nutrition and sleep of pregnant and delivery mothers can be seriously influenced, and even the healthy development of babies is influenced. Pain may even cause contractions, seriously compromising the safety of the baby and pregnant mother.
At present, no hemorrhoid treatment product which is well suitable for pregnant and lying-in women exists.
Disclosure of Invention
The application provides a haemorrhoids powder and haemorrhoids lotion has solved current haemorrhoids product and can not well be applicable to pregnant and lying-in woman crowd's technical problem, has realized being fit for pregnant and lying-in woman crowd and has used, and the effect of treatment haemorrhoids is obvious, and the medicinal material is mild, obtains easily, the technological effect of easy save.
The hemorrhoid powder provided by the application comprises the following components in parts by weight: 5-10 parts of astragalus membranaceus, 15-25 parts of golden cypress, 15-25 parts of radix angelicae, 10-20 parts of dandelion, 10-20 parts of fructus cnidii and 15-25 parts of purslane.
Based on the same inventive concept, the application also provides a preparation method of the hemorrhoid medicine powder, which comprises the following steps:
mixing 5-10 parts of astragalus membranaceus, 15-25 parts of golden cypress, 15-25 parts of radix angelicae, 10-20 parts of dandelion, 10-20 parts of fructus cnidii and 15-25 parts of purslane to obtain a mixture;
dissolving the mixture in purified water to obtain a mixed solution; the weight ratio of the purified water to the mixture is (5-8): 1;
extracting the mixed solution at constant temperature to obtain an extracting solution;
and concentrating, drying and pulverizing the extracting solution to obtain a finished product of the hemorrhoid medicine powder.
Preferably, the mixed solution is extracted at constant temperature in an extraction tank, the temperature is controlled to be 80-100 ℃, and the extraction time is controlled to be 7-12 hours.
Preferably, the temperature is controlled at 90 ℃, and the extraction time is controlled at 8 h.
Based on the same inventive concept, the application also provides a hemorrhoid lotion, which comprises the hemorrhoid powder and also comprises the following components: purified water, water-soluble algefacient, A.ASP antibacterial agent; the mixture ratio of each component is as follows: the hemorrhoid treatment solution comprises, by weight, 60-90 parts of purified water, 10-20 parts of hemorrhoid powder, 1-3 parts of water-soluble freshener and 1-5 parts of A.ASP antibacterial agent.
Based on the same inventive concept, the application also provides a preparation method of the hemorrhoid lotion, which comprises the following steps:
weighing and marking the hemorrhoid powder, purified water, water-soluble freshener and A.ASP antibacterial agent according to a certain proportion;
adding the weighed hemorrhoid medicine powder into the purified water for dissolving and homogenizing to obtain a dissolved solution;
stirring the solution;
adding the weighed water-soluble freshener and the weighed A.ASP antibacterial agent into the dissolved solution during stirring to obtain a mixed solution;
and continuously stirring the mixed solution, and obtaining a finished product of the hemorrhoid lotion after the temperature of the mixed solution is reduced to a set value.
Preferably, the hemorrhoid powder and the purified water are dissolved, homogenized and stirred in a stirring pot.
Preferably, the homogenizing time is controlled to be 4-8 min;
the set value of the temperature is 35-40 ℃.
Preferably, the stirring process is performed according to the following flow:
after the solution is stirred to be in a suspension state, heating and stirring the solution, and heating to 75-85 ℃;
heating and stirring until the dissolved solution is thoroughly dispersed, and stirring for 12-20 min at constant temperature;
after stirring at constant temperature, cooling and stirring the solution to 42-46 ℃;
after cooling and stirring, adding the weighed water-soluble freshener and the A.ASP antibacterial agent to obtain a mixed solution;
and cooling and stirring the mixed solution until the temperature of the mixed solution is reduced to 38 ℃, and then obtaining a finished product of the hemorrhoid lotion.
Preferably, the homogenization time is controlled to be 5 min;
after the solution is stirred to be in a suspension state, heating and stirring the solution, and heating to 80 ℃;
heating and stirring until the dissolved solution is completely dispersed, and stirring for 15min at constant temperature;
after stirring at constant temperature, cooling and stirring the solution, and cooling the temperature to 45 ℃.
One or more technical solutions provided in the embodiments of the present application have at least the following technical effects or advantages:
the hemorrhoid powder and hemorrhoid lotion do not contain components of Moschus, sanguis Draxonis, Borneolum Syntheticum, calculus bovis, Alumen, hormone or antibiotic which are forbidden to be used with caution for pregnant women, and can help pregnant and lying-in women hemorrhoid patients get rid of pain, swelling, hemorrhage, etc. caused by hemorrhoid. The medicinal materials of the hemorrhoid powder are mild and easy to obtain, and the hemorrhoid powder can be extracted, concentrated and powdered in batches and is easy to store. The hemorrhoid lotion has strong bacteriostatic action, the bacteriostatic rate on escherichia coli and staphylococcus aureus reaches more than 90%, and the hemorrhoid lotion has obvious treatment effect, and the effect is obvious, and generally takes effect in 3-7 days. Therefore, the technical problem that the existing hemorrhoid product cannot be well suitable for pregnant and lying-in women is solved, the hemorrhoid treatment effect is obvious, medicinal materials are mild, and the hemorrhoid treatment effect is easy to obtain and store.
Drawings
FIG. 1 is a schematic flow chart of a method for preparing hemorrhoid powder according to the embodiment of the present application;
FIG. 2 is a schematic flow chart of a method for preparing hemorrhoid lotion provided by the embodiment of the present application.
Detailed Description
In order to make the objects, technical solutions and advantages of the present application more apparent, embodiments of the present invention will be described in further detail below with reference to the accompanying drawings.
The application provides a haemorrhoids powder, which comprises the following components in parts by weight: 5-10 parts of astragalus membranaceus, 15-25 parts of golden cypress, 15-25 parts of radix angelicae, 10-20 parts of dandelion, 10-20 parts of fructus cnidii and 15-25 parts of purslane.
Wherein, the astragalus has the efficacies of invigorating spleen and replenishing qi, consolidating superficies, inducing diuresis, suppurative sepsis and promoting tissue regeneration, and has good curative effects on long-term ulcer and unhealing swelling; cortex Phellodendri has antibacterial, heat and toxic materials clearing away, pathogenic fire purging, and dampness eliminating effects; radix Angelicae Dahuricae has effects of dispelling pathogenic wind, eliminating dampness, relieving pain, expelling pus, and promoting granulation; the dandelion has the effects of clearing away heat and toxic materials, relieving swelling and resolving masses; fructus Cnidii has effects of eliminating dampness, dispelling pathogenic wind, killing parasite, and relieving itching; herba Portulacae has effects of clearing heat, promoting diuresis, removing toxic substance, relieving swelling, and relieving inflammation.
Based on the same inventive concept, the application also provides a preparation method of the hemorrhoid medicine powder, which is shown in the attached figure 1 and comprises the following steps:
s1: mixing 5-10 parts of astragalus membranaceus, 15-25 parts of golden cypress, 15-25 parts of radix angelicae, 10-20 parts of dandelion, 10-20 parts of fructus cnidii and 15-25 parts of purslane to obtain a mixture;
s2: dissolving the mixture in purified water to obtain a mixed solution; the weight ratio of the purified water to the mixture is (5-8): 1;
s3: extracting the mixed solution at constant temperature to obtain an extracting solution;
s4: concentrating, drying and pulverizing the extract to obtain the finished product of the hemorrhoid powder.
Further, the mixed solution is extracted at a constant temperature in an extraction tank, the temperature is controlled to be 80-100 ℃, and the extraction time is controlled to be 7-12 hours. As a preferred embodiment, the temperature is controlled at 90 ℃ and the extraction time is controlled at 8 h.
The specific process of the preparation method of the hemorrhoid medicine powder is described in detail by the following specific examples:
example 1
5 parts of astragalus, 15 parts of phellodendron, 15 parts of angelica dahurica, 10 parts of dandelion, 10 parts of fructus cnidii and 15 parts of purslane are mixed according to a certain proportion, 5 times of purified water is added to soak the mixture in an extraction tank for 24 hours, the soaked mixture is extracted for 8 hours at a constant temperature of 90 ℃, then the extracting solution is concentrated, dried and prepared into powder, and finally the yield is about 20 percent.
Example 2
The preparation method comprises the following steps of mixing 7 parts of astragalus membranaceus, 21 parts of golden cypress, 20 parts of angelica dahurica, 16 parts of dandelion, 12 parts of fructus cnidii and 22 parts of purslane in proportion, adding 6 times of purified water, soaking for 24 hours in an extraction tank, extracting at a constant temperature of 90 ℃ for 8 hours after soaking, concentrating, drying and pulverizing an extracting solution, and finally obtaining the yield of about 20%.
Example 3
10 parts of astragalus, 25 parts of phellodendron, 25 parts of angelica dahurica, 20 parts of dandelion, 20 parts of fructus cnidii and 25 parts of purslane, mixing the raw materials in proportion, adding 8 times of purified water, soaking the mixture in an extraction tank for 24 hours, extracting the mixture at a constant temperature of 90 ℃ for 8 hours after soaking, concentrating, drying and pulverizing the extracting solution, and finally obtaining the yield of about 20 percent.
Based on the same inventive concept, the application also provides a hemorrhoid lotion, which comprises the hemorrhoid powder and also comprises the following components: purified water, water-soluble algefacient, A.ASP antibacterial agent; the mixture ratio of each component is as follows: the hemorrhoid treatment solution comprises, by weight, 60-90 parts of purified water, 10-20 parts of hemorrhoid powder, 1-3 parts of water-soluble freshener and 1-5 parts of A.ASP antibacterial agent.
Based on the same inventive concept, the application also provides a preparation method of the hemorrhoid lotion, which is shown in the attached figure 2 and comprises the following steps:
s1: weighing and marking the hemorrhoid powder, purified water, water-soluble freshener and A.ASP antibacterial agent according to a certain proportion;
s2: adding the weighed hemorrhoid powder into purified water for dissolving and homogenizing to obtain a dissolved solution;
s3: stirring the solution;
s4: adding the weighed water-soluble freshener and the A.ASP antibacterial agent into the dissolved solution during stirring to obtain a mixed solution;
s5: and continuously stirring the mixed solution, and obtaining a finished product of the hemorrhoid lotion after the temperature of the mixed solution is reduced to a set value.
Further, the hemorrhoid powder and the purified water are dissolved, homogenized and stirred in a stirring pot. The homogenizing time is controlled to be 4-8 min; the set value of the temperature is 35-40 ℃.
Wherein the stirring process is performed according to the following flow:
after the solution is stirred to be in a suspension state, heating and stirring the solution, and heating to 75-85 ℃;
heating and stirring until the dissolved solution is thoroughly dispersed, and stirring for 12-20 min at constant temperature;
after stirring at constant temperature, cooling and stirring the solution to 42-46 ℃;
after cooling and stirring, adding the weighed water-soluble freshener and the A.ASP antibacterial agent to obtain a mixed solution;
and cooling and stirring the mixed solution until the temperature of the mixed solution is reduced to 38 ℃, and then obtaining a finished product of the hemorrhoid lotion.
As a preferred embodiment, the time for homogenization is controlled to be 5 min; after the solution is stirred to be in a suspension state, heating and stirring the solution, and heating to 80 ℃; heating and stirring until the dissolved solution is completely dispersed, and stirring for 15min at constant temperature; after stirring at constant temperature, cooling and stirring the solution, and cooling the temperature to 45 ℃.
The specific process and product effect of the preparation method of the hemorrhoid lotion are described in detail by the following specific examples:
example 4
Weighing all the components in proportion (by weight, 70 parts of purified water, 12 parts of hemorrhoid powder, 1.5 parts of water-soluble freshener and 3 parts of A.ASP antibacterial agent), labeling → inspecting a stirring pot and related operating tools and containers, ensuring clean cleaning and disinfection → adding the purified water and the hemorrhoid powder into the stirring pot, homogenizing for 4min, rapidly stirring to keep a suspension state → stirring and heating to 75 ℃, completely dispersing, keeping the temperature for 12min → cooling to 42 ℃, adding the water-soluble freshener and the A.ASP antibacterial agent → continuously stirring and cooling to 35 ℃.
Example 5
Weighing all the components in proportion (by weight, 70 parts of purified water, 18 parts of hemorrhoid powder, 2.5 parts of water-soluble freshener and 3 parts of A.ASP antibacterial agent), labeling → inspecting a stirring pot and related operating tools and containers, ensuring clean cleaning and disinfection → adding the purified water and the hemorrhoid powder into the stirring pot, homogenizing for 5min, rapidly stirring to keep a suspension state → stirring and heating to 78 ℃, completely dispersing, keeping the temperature for 14min → cooling to 44 ℃, adding the water-soluble freshener and the A.ASP antibacterial agent → continuously stirring and cooling to 36 ℃.
Example 6
Weighing all the components in proportion (by weight, 81.5 parts of purified water, 15 parts of hemorrhoid powder, 1.5 parts of water-soluble freshener and 2 parts of A.ASP antibacterial agent), labeling → inspecting a stirring pot and related operating tools and containers, ensuring clean cleaning and disinfection → adding the purified water and the hemorrhoid powder into the stirring pot, homogenizing for 5min, rapidly stirring and keeping a suspension state → stirring and heating to 80 ℃, completely dispersing, keeping the temperature for 15min → cooling to 45 ℃, adding the water-soluble freshener and the A.ASP antibacterial agent → continuously stirring and cooling to 38 ℃.
Example 7
Weighing all the components in proportion (84 parts by weight of purified water, 16 parts by weight of hemorrhoid powder, 2.5 parts by weight of water-soluble freshener and 4 parts by weight of A.ASP antibacterial agent), labeling → inspecting a stirring pot and related operating tools and containers, ensuring clean cleaning and disinfection → adding the purified water and the hemorrhoid powder into the stirring pot, homogenizing for 7min, rapidly stirring to keep a suspension state → stirring to raise the temperature to 82 ℃, completely dispersing, keeping the temperature for 18min → cooling to 46 ℃, adding the water-soluble freshener and the A.ASP antibacterial agent → continuously stirring to lower the temperature to 40 ℃, and thus completing the preparation.
The hemorrhoid lotion obtained in the above embodiments 4 to 7 is used for treating and tracking and recording different pregnant and lying-in women hemorrhoid patients, and the following clinical data are obtained:
the patients: some of Song; symptoms are: meatball swelling and pain, bleeding; treatment follow-up conditions: the lotion is used for two times every day for 4 days after 29 weeks of pregnancy, and is not swollen, painful and bloody.
The patients: slowly taking certain; symptoms are: the meat balls have severe swelling and pain; treatment follow-up conditions: in 32 weeks of pregnancy, the swelling and pain become more severe, and after 3 days, the feeling is particularly good and no pain is caused.
The patients: king certain; symptoms are: swelling and pain; treatment follow-up conditions: the preparation is used for 38 weeks without pain after 4 days.
The patients: king certain; symptoms are: thrombosed hemorrhoids; treatment follow-up conditions: after 25 weeks of pregnancy, no bleeding and swelling pain after 5 days of washing and application.
The patients: yao Yi (some of Yao); symptoms are: swelling and pain with bleeding, with a prominent feeling; treatment follow-up conditions: the pregnant woman feels no bleeding, no pain and much comfort after being washed and applied for 4 days after being pregnant for 22 weeks.
The patients: wu Chi; symptoms are: swelling and pain with hemorrhage; treatment follow-up conditions: after 28 weeks of pregnancy, the swelling and pain are relieved after washing and applying for 2 days, and no bleeding occurs.
The patients: some Liu; symptoms are: bleeding of external hemorrhoids; treatment follow-up conditions: in the lactation period, no bleeding occurred after 3 days of washing and application.
The patients: somebody of king; symptoms are: swelling and pain of meat balls; treatment follow-up conditions: the pregnant woman is 29 weeks, and the pain is avoided after washing and applying for 2 days, and the swelling is avoided after 4 days.
The patients: yan a certain point; symptoms are: hard and painful meatballs; treatment follow-up conditions: in the later stage of pregnancy, the pain is not produced after washing and applying for 4 days.
The patients: turning a vehicle; symptoms are: swelling and pain of external hemorrhoid; treatment follow-up conditions: after 50 days of delivery, the pain is not relieved after washing and applying for 5 days.
The patients: yan a certain; symptoms are: red and swollen; treatment follow-up conditions: after 21 weeks of pregnancy, the swelling subsides after washing and applying for 2 days.
The patients: some of Lu; symptoms are: swelling and pain of meat balls; treatment follow-up conditions: after delivery, the medicine is not swollen and does not feel painful after being used for 5 days.
The patients: wan somebody; symptoms are: red swelling, bleeding; treatment follow-up conditions: it is used for 4 days without swelling and bleeding.
The patients: dong a certain thing; symptoms are: swelling and pain of meat balls; treatment follow-up conditions: it is used for 6 days without swelling and pain.
The patients: a certain Chua; symptoms are: swelling and pain of meat balls; treatment follow-up conditions: in the late pregnancy, the medicine is not swollen and painful after being used for 7 days.
The patients: king certain; symptoms are: red swelling, pain, and sometimes bleeding; treatment follow-up conditions: after 34 weeks of pregnancy, the medicine is used for 5 days without swelling, pain and bleeding.
The patients: a certain uterus; symptoms are: bleeding of external hemorrhoids; treatment follow-up conditions: after delivery, no bleeding occurred after 2 days of use.
The patients: opening a certain page; symptoms are: meatball swelling; treatment follow-up conditions: after delivery, the swelling subsided after 2 days of use.
The patients: standing waves by antidune a certain; symptoms are: swelling and pain of meat balls; treatment follow-up conditions: the medicine is used for 32 weeks after pregnancy, and the swelling is relieved after 5 days without pain.
The patients: a certain hair; symptoms are: swelling and pain of meat balls; treatment follow-up conditions: the pregnant woman is 16 weeks, and the pregnant woman is not swollen and does not feel pain after being used for 3 days.
The patients: opening a certain page; symptoms are: swelling and pain of meat ball and hemorrhage; treatment follow-up conditions: the medicine can be used for 2 days without bleeding, and after 6 days, the medicine can not be swollen and painful.
The patients: a certain amount of Wei; symptoms are: swelling and pain of meat balls; treatment follow-up conditions: the medicine is used for 2 days without swelling and pain.
The patients: any one of the above; symptoms are: swelling and pain of meat balls; treatment follow-up conditions: after delivery, the medicine is not swollen and painful after being used for 4 days.
The patients: zhao a certain place; symptoms are: internal hemorrhoid with swelling and pain, stool will come out; treatment follow-up conditions: seven months of pregnancy, no swelling and pain of the meat ball after 7 days of use, and no loose stool.
The patients: somebody in summer; symptoms are: mixed hemorrhoids with red and swollen; treatment follow-up conditions: after 6 days of use, the meat balls on the outside are not swollen and are not painful, and the inside is comfortable.
The patients: somewhere else hu; symptoms are: external hemorrhoidal pain, occasional bleeding; treatment follow-up conditions: the product is painless and has no bleeding after 5 days.
The patients: somebody of week; symptoms are: meatball swelling, occasional bleeding; treatment follow-up conditions: after 3 days of use, no bleeding occurred, and after 5 days, no pain occurred.
The patients: generation of a certain; symptoms are: swelling and pain of meat ball and hemorrhage; treatment follow-up conditions: the pain and bleeding did not occur after 3 days of washing and application.
Thousands of pregnant and lying-in women patients treated by the hemorrhoid lotion are not repeated herein.
In summary, the hemorrhoid lotion and the preparation method of the embodiment of the application have at least the following beneficial effects:
the mild traditional Chinese medicinal materials which can be used by pregnant and lying-in women are selected, the lotion does not contain components which are forbidden to be used by pregnant and lying-in women, such as musk, dragon's blood, borneol, bezoar, alum, hormone or antibiotics and the like, the prepared hemorrhoid lotion is simple in process, easy in obtaining of raw materials, easy to store after batch extraction, concentration and powder preparation, obvious in effect of treating hemorrhoid, effective in 3-7 days generally, and capable of helping pregnant and lying-in women hemorrhoid patients to get rid of symptoms such as pain, swelling and bleeding caused by hemorrhoid. Has strong bacteriostasis, and the bacteriostasis rate to colibacillus and staphylococcus aureus reaches more than 90 percent.
The above-mentioned embodiments, objects, technical solutions and advantages of the present invention are further described in detail, it should be understood that the above-mentioned embodiments are only illustrative of the present invention and are not intended to limit the present invention, and any modifications, equivalents, improvements and the like made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (10)
1. The hemorrhoid medicine powder is characterized by comprising the following components in parts by weight: 5-10 parts of astragalus membranaceus, 15-25 parts of golden cypress, 15-25 parts of radix angelicae, 10-20 parts of dandelion, 10-20 parts of fructus cnidii and 15-25 parts of purslane.
2. A method of preparing the hemorrhoid powder of claim 1, comprising the steps of:
mixing 5-10 parts of astragalus membranaceus, 15-25 parts of golden cypress, 15-25 parts of radix angelicae, 10-20 parts of dandelion, 10-20 parts of fructus cnidii and 15-25 parts of purslane to obtain a mixture;
dissolving the mixture in purified water to obtain a mixed solution; the weight ratio of the purified water to the mixture is (5-8): 1;
extracting the mixed solution at constant temperature to obtain an extracting solution;
and concentrating, drying and pulverizing the extracting solution to obtain a finished product of the hemorrhoid medicine powder.
3. The preparation method of claim 2, wherein the mixed solution is extracted in an extraction tank at a constant temperature, the temperature is controlled to be 80-100 ℃, and the extraction time is controlled to be 7-12 hours.
4. The method of claim 3, wherein the temperature is controlled at 90 ℃ and the extraction time is controlled at 8 h.
5. A hemorrhoid lotion, characterized by comprising the hemorrhoid powder prepared by the preparation method of any one of claims 2 to 4, and further comprising the following components: purified water, water-soluble algefacient, A.ASP antibacterial agent; the mixture ratio of each component is as follows: 60-90 parts of purified water, 10-20 parts of the hemorrhoid powder, 1-3 parts of a water-soluble freshener and 1-5 parts of an A.ASP antibacterial agent.
6. A method of preparing the hemorrhoid lotion of claim 5, comprising the steps of:
weighing and marking the hemorrhoid powder, purified water, water-soluble freshener and A.ASP antibacterial agent according to a certain proportion;
adding the weighed hemorrhoid medicine powder into the purified water for dissolving and homogenizing to obtain a dissolved solution;
stirring the solution;
adding the weighed water-soluble freshener and the weighed A.ASP antibacterial agent into the dissolved solution during stirring to obtain a mixed solution;
and continuously stirring the mixed solution, and obtaining a finished product of the hemorrhoid lotion after the temperature of the mixed solution is reduced to a set value.
7. The method of claim 6, wherein the hemorrhoid powder and the purified water are dissolved, homogenized and stirred in a stirring kettle.
8. The method according to claim 6,
the homogenizing time is controlled to be 4-8 min;
the set value of the temperature is 35-40 ℃.
9. The method of claim 8, wherein the stirring process is performed according to the following procedure:
after the solution is stirred to be in a suspension state, heating and stirring the solution, and heating to 75-85 ℃;
heating and stirring until the dissolved solution is thoroughly dispersed, and stirring for 12-20 min at constant temperature;
after stirring at constant temperature, cooling and stirring the solution to 42-46 ℃;
after cooling and stirring, adding the weighed water-soluble freshener and the A.ASP antibacterial agent to obtain a mixed solution;
and cooling and stirring the mixed solution until the temperature of the mixed solution is reduced to 38 ℃, and then obtaining a finished product of the hemorrhoid lotion.
10. The method according to claim 9,
the homogenizing time is controlled to be 5 min;
after the solution is stirred to be in a suspension state, heating and stirring the solution, and heating to 80 ℃;
heating and stirring until the dissolved solution is completely dispersed, and stirring for 15min at constant temperature;
after stirring at constant temperature, cooling and stirring the solution, and cooling the temperature to 45 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911389193.3A CN110974882A (en) | 2019-12-30 | 2019-12-30 | Medicinal powder and lotion for treating hemorrhoid and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911389193.3A CN110974882A (en) | 2019-12-30 | 2019-12-30 | Medicinal powder and lotion for treating hemorrhoid and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110974882A true CN110974882A (en) | 2020-04-10 |
Family
ID=70078574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911389193.3A Pending CN110974882A (en) | 2019-12-30 | 2019-12-30 | Medicinal powder and lotion for treating hemorrhoid and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110974882A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113559195A (en) * | 2021-08-11 | 2021-10-29 | 陈先永 | Hemorrhoid medicine, hemorrhoid steam lotion and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1857499A (en) * | 2006-03-13 | 2006-11-08 | 叶明伟 | Fumigant for treating inflammatory external piles and its preparing method |
| CN101953928A (en) * | 2010-09-14 | 2011-01-26 | 岳莉 | Fumigation washing medicine for treating haemorrhoids and preparation method thereof |
| CN105497237A (en) * | 2016-01-20 | 2016-04-20 | 逄淑芳 | Traditional Chinese medicine used for treating hemorroide |
| CN105561066A (en) * | 2014-10-16 | 2016-05-11 | 丁国平 | Drug for treating hemorrhoids |
| CN107468797A (en) * | 2017-08-31 | 2017-12-15 | 蓝浩然 | A kind of hemorrhoids hemostasia particle and preparation method thereof |
-
2019
- 2019-12-30 CN CN201911389193.3A patent/CN110974882A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1857499A (en) * | 2006-03-13 | 2006-11-08 | 叶明伟 | Fumigant for treating inflammatory external piles and its preparing method |
| CN101953928A (en) * | 2010-09-14 | 2011-01-26 | 岳莉 | Fumigation washing medicine for treating haemorrhoids and preparation method thereof |
| CN105561066A (en) * | 2014-10-16 | 2016-05-11 | 丁国平 | Drug for treating hemorrhoids |
| CN105497237A (en) * | 2016-01-20 | 2016-04-20 | 逄淑芳 | Traditional Chinese medicine used for treating hemorroide |
| CN107468797A (en) * | 2017-08-31 | 2017-12-15 | 蓝浩然 | A kind of hemorrhoids hemostasia particle and preparation method thereof |
Non-Patent Citations (4)
| Title |
|---|
| 何清邻主编: "《现代中医临床》", 31 March 2019, 吉林科学技术出版社 * |
| 白国民 等: "清热燥湿法治疗混合痔术后肛门疼痛90例临床观察", 《河北中医》 * |
| 董育京 等: "银黄消痔散治疗痔疮84例", 《实用中医药杂志》 * |
| 金风玉露编著: "《古今单验方选评》", 31 August 2013, 辽宁科学技术出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113559195A (en) * | 2021-08-11 | 2021-10-29 | 陈先永 | Hemorrhoid medicine, hemorrhoid steam lotion and preparation method thereof |
| CN113559195B (en) * | 2021-08-11 | 2022-02-25 | 陈先永 | Externally-applied hemorrhoid medicine, hemorrhoid steam lotion and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102697961B (en) | Gynecological cleaning solution and preparation method thereof | |
| CN105998972A (en) | Bacteriostatic gel | |
| CN104547988A (en) | Tibetan medicine medicated bath for treating psoriasis and use method thereof | |
| CN102205078A (en) | High-efficiency compound lightyellow sophora root lotion and preparation method thereof | |
| CN102000145B (en) | Traditional Chinese medicine and western medicine compound infusion liquid for preventing and treating endometritis of dam and preparing method thereof | |
| CN106619780A (en) | Gynecological antibacterial gel | |
| CN110974882A (en) | Medicinal powder and lotion for treating hemorrhoid and preparation method thereof | |
| CN116115702B (en) | Flavored honeycomb pill composition and application thereof | |
| CN103656025A (en) | Medicinal liquor for traumatic injuries | |
| CN110841017A (en) | Hemorrhoid powder, hemorrhoid medicine and preparation method | |
| CN110393768A (en) | A kind of combined traditional Chinese medicine dabbling drug of Gilt Uterus anti-inflammatory and its preparation method and application | |
| CN108938703A (en) | The gynecological gel of quick antibacterial | |
| CN102670976B (en) | Heath-care gynecological lotion | |
| KR20010029068A (en) | Vaginal Troche Containing Jukyum and Mica | |
| CN1038761A (en) | Orthopedics department external application medicated powder medicated wine preparation and using method thereof | |
| CN111358915A (en) | Traditional Chinese medicine for treating congenital muscular torticollis and preparation method thereof | |
| CN102028873B (en) | Tannin berberine gel for treating cervical erosion and preparation process thereof | |
| CN1076864A (en) | Skin health-care liquid | |
| CN107854542A (en) | A kind of Chinese medicine preparation for treating inside and outside hemorrhoid and preparation method thereof | |
| CN103948709B (en) | Palace, a kind of Uygur medicine heat seal Meikang suppository and preparation method thereof | |
| CN107583016A (en) | A kind of cream for treating eczema and preparation method thereof | |
| CN116603025A (en) | A topical pharmaceutical composition for treating female reproductive system inflammation and infertility | |
| CN106822697B (en) | Chinese medicine for relaxing bowels, preparation using same and preparation method | |
| CN105477015A (en) | External-use traditional Chinese medicine lotion for postoperative anal fistula and preparation method thereof | |
| CN105661053A (en) | Plant sheep feed additive |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200410 |